When is high-dose intravenous iron repletion needed? Assessing new treatment options

References

• NemethEGanzTThe role of hepcidin in iron metabolismActa Hematol20091222–37886
   PubMed Web of Science ®Google Scholar
• CraigRMindellJHealth Survey for England 2005: The Health of Older People1LondonTSO2007
   Google Scholar
• De BenoistBMcLeanEEgliICogswellMWorldwide Prevalence of Anemia 1993–2005: WHO Global Database on AnemiaGenevaWorld Health Organisation2005
   Google Scholar
• BesarabAAminNAhsanMOptimization of epoetin therapy with intravenous iron therapy in hemodialysis patientsJ Am Soc Nephrol20001153053810703677
   PubMed Web of Science ®Google Scholar
• MelamedNBen-HaroushAKaplanBYogevYIron supplementation in pregnancy – does the preparation matter?Arch Gynecol Obstet2007276660160417541618
   PubMedGoogle Scholar
• LawrenceRDevelopment and comparison of iron dextran productsPDA J Pharm Sci Technol19985251901979846066
   PubMedGoogle Scholar
• Venofer® [Package insert]Surrey, UKSyner-med Pharmaceutical Products Ltd2010
   Google Scholar
• Cosmofer® [Package insert]Holbaek, DenmarkPharmacosmos A/S2010
   Google Scholar
• Ferrlecit® [Monograph]Bridgewater, NJSanofi-aventis US LLC2010
   Google Scholar
• Feraheme® [Monograph]Cambridge, MAAMAG Pharmaceuticals Inc2009
   Google Scholar
• Ferinject® [Package insert]Surrey, UKSyner-med Pharmaceutical Products Ltd2010
   Google Scholar
• Monofer® [Package insert]Cambridge, MAAMAG Pharmaceuticals Inc2010
   Google Scholar
• PeeblesGStanleySEvaluation of service reconfiguration for managing intravenous iron supplementation in non-hemodialysis patients with chronic renal failureJournal of Outcomes Research200481525
   Google Scholar
• JenkinsAUsing iron dextran to treat iron-deficiency anemiaHospital Pharmacist2005126224225
   Google Scholar
• AuerbachMCoyneDBallardHIntravenous iron: From anathema to standard of careAm J Hematol200883758058818273906
   PubMed Web of Science ®Google Scholar
• AgarwalRIndividualizing decision-making – resurrecting the doctor-patient relationship in the anemia debateClin J Am Soc Nephrol2010571340134620448071
   PubMed Web of Science ®Google Scholar
• The Renal AssociationClinical Practice Guidelines: Chronic Kidney DiseaseHampshire, UKThe Renal Association2010
   Google Scholar
• JungersPQualimZNguyen-KhoaTMasseyZLondonGCardioprotection: An essential component for predialysis chronic renal failure treatmentNephrologie20032427988 French.12723513
   PubMedGoogle Scholar
• MacdougallICIron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: Oral or intravenous?Curr Med Res Opin201026247348220014980
   PubMed Web of Science ®Google Scholar
• GanzoniAMSchweiz Med Wochenschr19701007301303 German. [Intraverous iron-deptran: therapeutic and experimental possibilities]. [German]5413918
   PubMedGoogle Scholar
• PeeblesGFenwickSIntravenous iron administration in a short-stay hospital settingNurs Stand20082248354118727354
   PubMedGoogle Scholar
• GascheCLomerMCECavillWeissGIron, anemia, and inflammatory bowel diseaseGut2004531190119715247190
   PubMed Web of Science ®Google Scholar
• GascheCBerstadABefritsRGuidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseaseInflamm Bowel Dis200713121545155317985376
   PubMed Web of Science ®Google Scholar
• BothwellTHIron requirements in pregnancy and strategies to meet themAm J Clin Nutr2000721S257S264
   Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceAntenatal care: Routine Care for the Healthy Pregnant Woman. Clinical GuidelineLondon, UKNational Institute for Health and Clinical Excellence2008
   Google Scholar
• BashiriASmolinASheinerEZelingherJMazorMMaternal rehospitalization after singleton term vaginal deliveryJ Matern Fetal Neonatal Med200314534434814986810
   PubMedGoogle Scholar
• KnightMCallaghanWMBergCTrends in postpartum hemorrhage in high resource countries: A review and recommendations from the International Postpartum Hemorrhage Collaborative GroupBMC Pregnancy Childbirth200995519943928
   PubMed Web of Science ®Google Scholar
• Royal College of Obstetricians and GynecologistsNational Sentinel Caesarean Section Audit (England, Wales and Northern Ireland)London, UKRoyal College of Obstetricians and Gynecologists Press2001
   Google Scholar
• BreymannCThe use of iron sucrose complex for anemia in pregnancy and the postpartum periodSemin Hematol200643Suppl 6S28S31
   Web of Science ®Google Scholar
• BodnarLMSiega-RizAMMillerWCCogswellMEMcDonaldTWho should be screened for postpartum anemia? An evaluation of current recommendationsAm J Epidemiol20021561090391212419762
   PubMed Web of Science ®Google Scholar
• HallakMSharonASDiukmanRAuslenderRAbramoviciHSupplementing iron intravenously in pregnancy. A way to avoid blood transfusionsJ Reprod Med1997422991039058345
   PubMed Web of Science ®Google Scholar
• QunibiWDinhQBenjaminJSafety and tolerability profile of ferric carboxymaltose (FCM) a new high dose intravenous iron, across ten multi-center trialsJ Am Soc Nephrol200718 SU–PO1029.
   Google Scholar
• ProtheroeJModern management of menorrhagiaJ Fam Plann Reprod Health Care200430211812215087000
   PubMedGoogle Scholar
• OehlerMKReesMCMenorrhagia: An updateActa Obstet Gynecol Scand200382540542212752071
   PubMed Web of Science ®Google Scholar
• MorrisonJPatelSTWatsonWZaidiQRMangioneAGossTFAssessment of the prevalence and impact of anemia on women hospitalized for gynecologic conditions associated with heavy uterine bleedingJ Reprod Med200853532333018567277
   PubMed Web of Science ®Google Scholar
• LoLModern management of menorrhagiaHong Kong Practitioner19961826266
   Google Scholar
• PrenticeAMedical management of menorrhagiaBMJ19993191343134510567142
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceHeavy Menstrual Bleeding. Clinical GuidelineLondon, UKNational Institute for Health and Clinical Excellence2007
   Google Scholar
• KimYHChungHHKangSBKimSCKimYTSafety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: A phase IV, open label, prospective, randomized studyActa Haematol20091211374119332985
   PubMed Web of Science ®Google Scholar
• Van WyckDBMangioneAMorrisonJHadleyPEJehleJAGoodnoughLTLarge-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: A randomized, controlled trialTransfusion200949122719272819682342
   PubMed Web of Science ®Google Scholar
• BokemeyerCAaproMSCourdiAEuropean Organisation for Research and Treatment of Cancer (EORTC) Taskforce for the ElderlyEORTC guidelines for the use of erythropoietic proteins in anemic patients with cancerEur J Cancer200440152201221615454245
   PubMed Web of Science ®Google Scholar
• CrawfordJCellaDCleelandCSRelationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin-alfa therapyCancer200295488889512209734
   PubMed Web of Science ®Google Scholar
• WeissGPathogenesis and treatment of anemia of chronic diseaseBlood Rev2002162879612127952
   PubMed Web of Science ®Google Scholar
• AuerbachMShould intravenous iron be the standard of care in oncologyJ Clin Oncol200826101579158118375888
   PubMed Web of Science ®Google Scholar
• FishbaneSFreiGLMaesakaJReduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementationAm J Kidney Dis199526141467611266
   PubMed Web of Science ®Google Scholar
• AuerbachMBallardHTroutJRIntravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy related anemia: A multicenter, open label, randomized trialJ Clin Oncol20042271301130715051778
   PubMed Web of Science ®Google Scholar
• HenryDHDahlNVAuerbachMTchekmedyianSLaufmanLRIntravenous ferric gluconate improves response to epoietin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapyOncologist200712223124217296819
   PubMed Web of Science ®Google Scholar
• BastitLVandebroekAAltintasSRandomized, multicenter, controlled trial comparing the efficacy and safety of darbepoietin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemiaJ Clin Oncol200826101611161818375890
   PubMed Web of Science ®Google Scholar
• PedrazzoliPFarrisADel PreteSRandomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoietin alfaJ Clin Oncol200826101619162518375891
   PubMed Web of Science ®Google Scholar
• American Society of Clinical OncologyImportant information for physicians about changes affecting the FDA-approved use of erythropoiesis stimulating agents (ESA) Available from: http://www.asco.org/ASCO/ArticleASCO/Cancer%20Policy%20and%20Clinical%20Affairs/Policy/MMA%20Regulation%20&%20Resources/erythropoieticstimulatingagents%20Doc%20for%20Practicing%20Oncologists%20092508%20FINAL.pdf. Accessed Jun 8 2010.
   Google Scholar
• SteensmaDPIs anemia of cancer different from chemotherapy induced anemia?J Clin Oncol20082671022102418227523
   PubMed Web of Science ®Google Scholar
• SinghAKTangKLBamhartHCHOIR investigatorsCorrection of anemia with epoietin alfa in chronic kidney diseaseN Engl J Med2006355202085209817108343
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceErythropoietin analogues for anemia caused by cancer treatment. Technology appraisal guidanceLondon, UKNational Institute for Health and Clinical Excellence2008
   Google Scholar
• AaproMSLinkHSeptember 2007 Update on EORTC guidelines and anemia management with erythropoiesis-stimulating agentsOncologist200813Suppl 3333618458123
   PubMed Web of Science ®Google Scholar
• SteensmaDPNew ASH/ASCO guidelines on the use of erythropoiesis-stimulating agents: A chorale amid cacophonyJ Support Oncol200751047147318240668
   PubMedGoogle Scholar
• Special EurobarometerHealth and Food 246/Wave 643 – TNS Opinion and SocialEuropean Commission2006
   Google Scholar
• PortierKTolsonJKRobertsSMBody weight distributions for risk management. (NHANES 1999–2002)Risk Anal2007271112617362397
   PubMed Web of Science ®Google Scholar
• European Pharmacopoeia – Monograph. Page 1408.
   Google Scholar
• Luitpold Pharmaceuticals Inc19th July 2007Methods and Compositions for Administration of Iron WO2007/081744 A2.
   Google Scholar
• KulniggSStoinovSSimanenkovVA novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: The ferric carboxymaltose (FERINJECT) randomized controlled trialAm J Gastroenterol200810351182119218371137
   PubMed Web of Science ®Google Scholar
• WysowskiDKSwartzLBorders-HemphillBVUse of parenteral iron products and serious anaphylactic-type reactionsAm J Hematol201085965065420661919
   PubMed Web of Science ®Google Scholar
• ChertowGMWinkelmayerWCOn the relative safety of intravenous iron formulations: New answers, new questionsAm J Hematol201085964364420687100
   PubMed Web of Science ®Google Scholar